The nomination deadline for The Abarca Prize has passed, and we extend our heartfelt gratitude to all institutions and organizations that submitted their nominations.👏

Moving forward, the Committee of Experts will assess the suitability of the candidates.

We spotlight the winner of the The Abarca Prize 2023: Douglas Melton, Co-Director of the HSCI and researcher at Vertex Pharmaceuticals. His groundbreaking work aims to cure type 1 #diabetes by developing #stemcell therapies that could eliminate the need for #insulin injections.

🧬Hoy compartimos un #estudio que revela avances en la creación de mini órganos fetales humanos a partir del líquido amniótico, sin riesgo para el #feto o la madre. Estos podrían transformar el tratamiento de #enfermedades congénitas.

elpais.com/ciencia/2024-0… EL PAÍS España

👩‍⚕️Dr. Leticia Fernandez Friera, Head of the Cardiology Department at HM HOSPITALES, highlights the importance of the The Abarca Prize in recognizing individuals devoted to advancing science for better #patientcare .

'It's a great honor for me to represent this commitment to progress.'

💉In a historic human clinical trial, an #mRNA #cancer #vaccine from the UniversityofFlorida swiftly targeted the aggressive glioblastoma brain tumor with unprecedented efficacy.

More information: sciencedaily.com/releases/2024/…

👨‍🔬Professor Casanova Lab, winner of the 2022 The Abarca Prize, Head of the Human Genetics of Infectious Diseases Laboratory at the Imagine Institute and Head of the St. Giles Laboratory at Rockefeller University, feels fortunate to be a member of the jury for its second edition. #medicine

On #WorldAsthmaDay , we highlight new insights into this respiratory condition: inflammation triggered by environmental factors leads to bronchoconstriction. Despite treatments, research shows that mechanical damage to the airways complicates asthma healing.science.org/doi/10.1126/sc…

🎉Dr. Silvia Priori, a leading #cardiologist and #researcher , is the president of the jury for the 4th edition of the prestigious The Abarca Prize! She leads groundbreaking research on hereditary arrhythmias and directs the ICS Maugeri network.

More info at: abarcaprize.com/es/el-jurado-i…

🔍New #research in Nature Portfolio emphasizes the strong connection between dietary choices and #brainhealth . Analyzing nearly 182,000 participants, the study found that a #balanceddiet improves cognitive function and mental wellbeing.

More information: sciencedaily.com/releases/2024/…

📢The IV Edition of the The Abarca Prize is open for #nominations until the deadline in one month. This prestigious award acknowledges impactful medical-scientific advancements and innovations that have enhanced #health systems.
abarcaprize.com/nominations/

🔬Today we highlight the remarkable journey of #SeveroOchoa , an eminent Spanish scientist awarded The Nobel Prize in Physiology or Medicine in 1959. From an early age, he showed a profound interest in biology, focusing on the study of energy #metabolism .

They are the jury who will choose the next winner of #AbarcaPrize2024 , which has the purpose of recognizing the impact of #medicaladvances .

They will ensure a key perspective in selecting the winning candidate, who has made a significant contribution.

abarcaprize.com/the-jury-iv-ed…

Prof. Sansonetti, winner of the II Edition of The Abarca Prize, has revolutionized the study of shigellosis in sub-Saharan Africa. His work on childhood stunting and pediatric environmental enteropathy sheds light on the pathogenesis of this diarrheal disease.youtube.com/watch?v=dQMVKu…

La #vacuna del #ébola reduce a la mitad la probabilidad de morir por la enfermedad, según un estudio reciente de MSF International publicado en The Lancet. Además de detener la transmisión del virus, aumenta las tasas de supervivencia entre los infectados previamente.
elpais.com/planeta-futuro…

👨‍⚕️Dr. José A. Obeso stresses the importance of having a strong vocation and determination for aspiring #researchers dedicated to improving well-being. He emphasizes the need for dedication, #hardwork , and belief in achieving their goals despite challenges. youtube.com/watch?v=GMjTyk…

🧬 #Cholesin , a new #hormone , reduces liver cholesterol synthesis and circulating #cholesterol levels. It binds to GPR146, suppressing cholesterol production controlled by SREBP2.

This discovery may aid in treating hypercholesterolemia and atherosclerosis. NCBI

Dr. José María Castellano on the inaugural editions: 'Despite challenges, we've elevated the #AbarcaPrize to its deserved stature. With an esteemed jury, we've honored impactful scientists.
Their achievements promise societal transformation.'

youtube.com/watch?v=cIuV99…

🧬🧠En el #DiaMundialDelParkinson , compartimos un estudio de The Lancet reciente que analiza cómo las mutaciones en el ADN de pacientes con trastorno del sueño en fase REM podrían anticipar el desarrollo de #párkinson y #demencia .

msn.com/es-es/salud/ot…

👨‍⚕️Dr José A Obeso expresses that serving as the ambassador of the The Abarca Prize is personally rewarding as it signifies the trust of HM HOSPITALES and, specifically, the Abarca Cidón family in conveying and emphasizing the significance of this #award .

youtube.com/watch?v=EWI6pc…

The U.S. FDA has approved #Rezdiffra , the first medication to treat nonalcoholic steatohepatitis (NASH), a liver inflammation condition linked to obesity and metabolic disorders. Developed by Madrigal Pharmaceuticals, Rezdiffra addresses a significant medical need.
msn.com/en-us/health/o…